Moreover, 61% (72/118) of grade 4 gliomas showed highly positive staining for MAGOH/MAGOHB expression, significantly more than in grade 2 (29.6%) and grade 3 (41.17%) gliomas (p-value = 0.005, Figure 2B). The gene discussed is MAGOHB; the disease is central nervous system cancer.